Turning groundbreaking biotech research into real-world solutions is often hindered by the infamous “valley of death” — the critical gap where funding is scarce, risk is high, and startups often fail to take shape. We will explore how the venture builder model can play a transformative role in bridging that gap and accelerating the path from lab bench to market.
In this session, we will discover:
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
The best opportunity to learn and discuss common issues and interests directly with peers.
Ian Nicoud
LURIS, Netherlands
Recent studies on both sides of the Atlantic, directed by either ASTP or AUTM, demonstrate the tremendous economic and societal benefit and value technology transfer has brought us.
Koenraad Debackere
KU Leuven, Belgium
Technology transfer is ever changing and a key piece for the competitiveness of your institution, this course is an excellent tool to prepare yourself for that challenge.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
Great networking and learning opportunities to share knowledge with colleagues from their various areas of expertise.
Bruno Woeran
Merinova OY - TII President, Finland
ASTP has attained a unique position that has turned it into a highly valued player on the global technology transfer scene.
Koenraad Debackere
KU Leuven, Belgium
Join our newsletter and get the latest news